BDX — Becton Dickinson and Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Becton Dickinson and Co, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	R2020 September 30th	R2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	16,074	19,131	18,870	19,372	20,178
Cost of Revenue
Gross Profit	7,140	8,687	8,603	8,823	9,163
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	15,170	17,059	16,579	17,202	17,755
Operating Profit	904	2,072	2,291	2,170	2,423
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	414	1,692	1,783	1,662	2,005
Provision for Income Taxes
Net Income After Taxes	352	1,604	1,635	1,530	1,705
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	874	2,092	1,779	1,484	1,705
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	767	2,002	1,689	1,424	1,705
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	6.3	8.6	8.8	6.85	7.91
Dividends per Share